Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
Yoon Jin(Yonsei University), Hyo Sup Shim(Yonsei University)
Cited by 75
Related Papers
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
|Annals of Oncology|2013|125
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer
|Clinical Cancer Research|2020|116
Dysregulation of TFH-B-TRM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer
|Nature Communications|2021|64
Spatial analysis of tumor‐infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma
|The Journal of Pathology Clinical Research|2022|51
Highly Multiplexed Fluorescence in Situ Hybridization for in Situ Genomics
|Journal of Molecular Diagnostics|2019|21